Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-06-05 00:00:00 ET · period of report 2024-06-03 · accession 0001415889-24-015589 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-05 | 2024-06-03 | PCVX | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $21.41 | +1,667 | 32.8K | +5% | +$35.7K |
| DM | 2024-06-05 | 2024-06-03 | PCVX | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | S - Sale+OE | $72.06 | -1,667 | 31.2K | -5% | -$120.1K |
| D | 2024-06-05 | 2024-06-03 | PCVX | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $0.00 | -1,667 | 185.0K | -0.9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-03 | M | A | 1,667 | $21.41 | 32,828 | D | — | — | (F1) Includes 564 shares acquired under the Issuer's Employee Stock Purchase Plan on May 17, 2024. |
| 2 | Common | Common Stock | 2024-06-03 | S | D | 751 | $71.25 | 32,077 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $70.98 to $71.62. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2024-06-03 | S | D | 656 | $72.37 | 31,421 | D | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $72.08 to $72.67. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2024-06-03 | S | D | 260 | $73.64 | 31,161 | D | — | — | (F5) The price reported is a weighted-average price. The shares were sold at prices ranging from $73.46 to $73.82. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Derivative | Stock Option (right to buy) | 2024-06-03 | M | D | 1,667 | $0.00 | 184,998 | D | $21.41 · — to 2032-05-08 | 1,667 Common Stock | (F6) 1/4 of the shares subject to the option vested on April 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date. |